Controlling Depression May Help Control Glucose North Pole AK

People with both depression and diabetes in North Pole may benefit from regular use of antidepressant medications to help control blood sugar levels, according to a new study. Researchers from the Washington University School of Medicine in St. Louis studied 93 adult patients with type 2 diabetes who had major depression.

National Companies

Issa Ghosn MD
(850) 416-2340
5149 N 9th Ave
Pensacola, FL
Wasatch Endocrinology
(801) 746-0776
807 E South Temple
Salt Lake City, UT
Wound Healing Institute At Stevens Hospital
(425) 673-3382
Lynnwood, WA
Amelia Health Care Center
(804) 561-5150
8920 Otterburn Rd
Amelia Court House, VA
Saint Barnabas Ambulatory Care Center
(973) 322-7200
Livingston, NJ
Crowe Daniel J MD
(603) 433-5160
155 Borthwick Ave
Portsmouth, NH
Iqbal Farrukh MD Frcp Face
(702) 450-5002
100 N Green Valley Pkwy
Henderson, NV
Schuster Jane Rd
(505) 982-2860
1533 S Saint Francis Dr
Santa Fe, NM
Coakley Christopher E
(508) 746-7858
45 Resnik Rd
Plymouth, MA
Pedroza Escipion MD PHD
(504) 454-2816
4213 Saxon St
Metairie, LA

Provided By:

(iVillage Total Health) - People with both depression and diabetes may benefit from regular use of antidepressant medications to help control blood sugar levels, according to a new study.

Researchers from the Washington University School of Medicine in St. Louis studied 93 adult patients with type 2 diabetes who had major depression. Depression is a mental illness in which a person is profoundly sad and has a loss of interest in things he or she once found pleasurable. Previous studies have shown that having depression is an independent risk factor for developing type 2 diabetes.

The new study sought to determine if glycemic control improved while patients were treated with bupropion hydrochloride extended release (Wellbutrin XL), an antidepressant medication commonly prescribed to treat depression. Participants were given 150 milligrams (mg) each morning and the dosages were adjusted biweekly in 150 mg increments (up to a maximum of 450 mg a day). There were two phases to the study: a 10-week acute phase in which participants were given this continually increasing dosage, followed by a 24-week maintenance phase where they received the same level of medication.

Measurements of body mass index, total fat mass, blood glucose and adherence to diabetes self-care were taken at the outset and then periodically throughout the study. Researchers found that people treated with bupropion showed significant reductions in depression and improvements in glycemic control.

Copyright 2009 NBC Health

Click here to read the rest of the article at HealthVideo.com